查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853787

中央静脉导管市场按产品类型、应用、最终用户、管腔数量、材质和尖端形状划分－2025-2032年全球预测

Central Venous Catheters Market by Product Type, Application, End User, Lumen Number, Material, Tip Configuration - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，中央静脉导管市场规模将达到 54.9 亿美元，复合年增长率为 10.00%。

关键市场统计数据
基准年 2024 25.6亿美元
预计年份：2025年 28.1亿美元
预测年份 2032 54.9亿美元
复合年增长率 (%) 10.00%

对中央静脉导管在现代护理路径中的重要性进行了权威概述，重点介绍了临床、监管和供应链之间的相互依存关係。

中央静脉导管仍然是现代急性和慢性照护的重要组成部分，满足了不同患者群体在治疗、诊断和长期血管通路方面的关键需求。其应用范围广泛，包括血液血液透析机、长期输液治疗、中心静脉压监测和肠外营养，涉及医院、透析中心、门诊手术中心、居家照护机构和专科诊所等。随着临床需求的不断变化，导管本身也在不断改进，以提高安全性、耐用性和操作效率，同时与强调门诊病人管理和缩短住院时间的护理模式相适应。

材料、导管尖端结构和管腔设计的技术进步正在重塑临床医生的偏好和手术流程。同时，监管机构对器械安全性和感染预防的严格审查持续影响标籤、声明和上市后监测的重点。供应链的复杂性和采购政策进一步影响器械的选择和可用性，使得营运准备和供应商关係成为临床连续性的关键决定因素。本引言为深入探讨在临床、商业和政策层面重塑中央静脉导管策略的各种因素奠定了基础。

材料创新、分散式医疗服务和监管如何共同作用，重新定义医疗器材的设计、采购和临床应用。

中央静脉导管正经历着快速而多方面的变革，这主要得益于技术创新、不断变化的医疗环境以及支付者和监管机构期望的转变。如今，器械设计的进步融合了多种功能，例如瓣膜边缘技术、动力注射相容性、抗菌涂层和精密的管腔几何形状，每项功能都旨在满足特定的临床需求，例如降低感染风险、提高影像相容性和增强血流特性。同时，材料科学也取得了长足进步，聚氨酯和硅胶因其在柔韧性、血栓形成性和长期耐久性之间的平衡而成为首选材料。

同时，医疗服务模式正向分散化转变。门诊手术中心的扩张和完善的居家照护项目的推进，推动了对便于门诊植入、维护简便、可长期留置且併发症率极低的医疗器械的需求。基于价值的采购模式和对感染预防的日益重视，使得医疗总成本和临床医生培训成为推动医疗器材普及的关键因素。在监管方面，监管机构强调真实世界安全性和性能对比的证据，鼓励製造商投资临床试验和註册研究。最后，包括积层製造和供应商整合在内的製造和供应链创新，正在改变医疗器材的生产和分销方式，这不仅为本地化应对创造了机会，也带来了对单一来源依赖的风险。

了解2025年贸易措施对采购、供应韧性和製造商投资选择的策略和营运影响

2025年实施的最新关税政策改变了中央静脉导管生态系统中相关人员的成本会计和商业策略。对某些原材料和成品组件征收的进口关税增加了依赖全球供应链的製造商和经销商的采购成本。因此，各公司正在重新评估其供应商组合，协商长期合约以稳定投入成本，并评估近岸外包和区域采购，以降低关税波动和物流延误带来的风险。

这些贸易政策的变化也对医院的采购和竞标流程产生了后续影响。医疗系统和集团采购组织正在重新审视单位价格以外的总成本分析，将关税、合规费用和库存持有成本等因素纳入考量。对于小型製造商和利基供应商而言，关税环境加剧了利润压力，并可能限制其在产品开发和临床研究方面的投资。相较之下，拥有多元化製造地的大型企业可以利用其规模优势来吸收短期成本衝击，同时将生产策略性地转移到关税税率更为优惠的地区。

在营运方面，关税正在加速有关库存缓衝、双源筹资策略和供应商资格确认流程的讨论。由于采购团队需要在可用性和成本之间进行权衡，并强调在引入替代产品时需要进行全面的临床评估，临床医生可能会遇到暂时的设备替代情况。总而言之，在中央静脉导管产业，关税主导的动态正在重塑商业策略、供应链弹性计画和创新投资决策。

透过细分市场分析，揭示产品类型、临床用途、最终用户特征、管腔结构、材料和尖端形状如何相互影响，从而驱动器械选择。

深入了解产品类型细分对于根据临床需求选择合适的器材至关重要。植入式输液港、非隧道式导管、周边置入中央静脉导管（如开口式和带阀导管）以及隧道式导管（如Broviac、Groshong和Hickman导管）分别适用于不同的临床场景和预期使用时长。这些器械在置入技术、置入时间、感染风险和维护要求方面各不相同，因此临床医生需要根据患者的合併症、预期治疗时间和手术物流来选择特定类型的器械。

基于应用领域的细分明确了对特定功能的需求集中在哪里：血液透析机通路需要耐用的管腔和稳定的血流特性；输液治疗优先考虑留置可靠性和感染预防；监测需要稳定的导管尖端位置和图像兼容性；肠外营养优先考虑长期通畅性和生物相容性材料。最终使用者细分则影响分销和培训的重点，例如，门诊手术中心和专科诊所重视快速週转和简化的工作流程，透析中心优先考虑高吞吐量，居家医疗优先考虑易于维护的设备和看护者培训，而医院则需要管理最广泛的临床类型并严格遵守感染控制通讯协定。

单腔、双腔、三腔和四腔器械满足了各种联合治疗方法和同时给药的需求。聚氨酯和硅胶材质的选择体现了柔韧性、血栓形成性和长期稳定性之间的平衡。尖端几何形状区分了非动力式和动力式给药，这会影响其与影像方案和介入工作流程的兼容性。将这些细分维度与临床医生培训、供应链准备和报销实际情况相结合的协作式产品开发，将决定哪些器械类别在特定治疗路径中获得应用。

影响美洲、欧洲、中东和非洲以及亚太市场设备创新、监管策略和供应链方式的区域动态

区域动态对医疗器材设计重点、监管路径和筹资策略有显着影响。在美洲，密集的先进医院和透析中心网络促进了功能丰富的医疗器材的快速普及，而支付方结构和集团采购行为则影响着价格谈判和供应商关係。此外，美洲拥有强大的製造能力，为本地生产提供了机会，从而缓解跨境贸易压力，这在关税制度不断变化的今天尤其重要。

欧洲、中东和非洲是一个异质性区域，由于复杂的监管环境和多样化的医疗保健资金筹措模式，其应用模式各不相同。西方市场通常强调可靠的临床证据和上市后监测，而中东和非洲部分地区则更注重供应可靠性和成本效益。建立区域分销网络并与当地医疗机构建立合作关係，对于进入分散的市场并满足不同的临床实践和基础设施水平至关重要。

亚太地区工业蓬勃发展，国内製造业能力不断提升，医疗保健服务覆盖率的扩大也带动了市场需求的成长。各国法律规范的差异要求制定量身定制的打入市场策略，而能够实现生产和临床支援的本地化製造商往往更受青睐。在所有地区，跨境物流、关税政策和贸易措施都与区域采购规范相互作用，这凸显了在引入新型中央静脉导管技术时，制定区域性供应链策略和开展临床医生参与计画的重要性。

以技术创新、临床证据和供应链优化为核心的竞争策略如何重新定义企业的定位和成长路径

中央静脉导管领域的竞争格局由创新主导产品製造商、专业製造商和综合医疗设备製造商组成。市场参与企业在多个方面竞争，包括材料科学、导管尖端和管腔结构、感染预防功能以及操作人体工学。策略性措施通常围绕着以下几个方面：透过培训计画深化与临床医生的关係；透过临床研究和註册登记收集证据；以及透过与区域经销商和整合供应链合作伙伴建立合作关係来扩大分销管道。

创新投资日益聚焦于差异化价值提案，例如可动力注射的针头配置、降低血栓风险的阀门技术以及旨在降低感染率的表面处理技术。同时，商业策略优先考虑产品组合的广度，以满足从门诊输液到透析通路等多样化的终端用户需求。产业参与者也在优化其製造地并探索垂直整合，以提升品质和应对力，尤其是在供应链韧性成为竞争优势的情况下。併购和授权仍然是加速新技术普及和扩大地域覆盖范围的有效手段，而监管合规和上市后监测对于维持长期商业性绩效仍然至关重要。

製造商和医疗系统应专注于以下策略：加强供应链韧性、提升临床价值，并加速在各种医疗环境中推广应用。

产业领导者应优先考虑多管齐下的方法，在短期营运韧性与长期创新和临床价值创造之间取得平衡。加强供应商多元化并建立区域製造方案，可以缩短高优先级医院系统的前置作业时间，同时降低贸易中断带来的风险。除了供应链的努力外，投资于产生临床证据，以证明感染率更低、通畅率更高、手术效率更高，将有助于加强与支付者和采购委员会基于价值的对话。

製造商和经销商还必须根据门诊手术中心、透析中心、居家照护机构、医院和专科诊所的具体需求，量身定制产品和支援模式。将数位化技术应用于临床医生教育、库存管理和上市后监测，可以提高产品采用率，并提供性能数据，从而指导迭代式设计改进。最后，为了在以竞标主导的采购环境中保持竞争力，定价策略必须与已证实的疗效和总医疗成本相符。同时，与临床专家伙伴关係，可以推动高价值功能（例如电动注射器相容性和抗菌表面）的应用。

采用透明的混合方法，结合对临床医生和采购负责人的初步访谈以及系统性的二次综合分析，绘製出设备、临床和区域动态图。

这些研究成果的理论基础是将与临床医生、采购负责人和医疗器材製造商的初步定性访谈，与临床文献、监管文件和公开技术规范的系统性回顾相结合。研究人员透过初步访谈收集了关于器械选择标准、手术流程影响和采购限制等方面的现场观点。二次分析则结合了医疗设备设计趋势、材料科学发展和监管指南，以验证访谈结果的准确性。

細項分析将产品属性与临床用途、终端用户能力、管腔配置、材料特性和高级功能相匹配。区域评估纳入了贸易政策分析、医疗基础设施指标和观察到的分销模式。为增强研究结果的可靠性，我们透过与多方相关人员访谈并与临床实践指南进行比较，对研究结果进行了交叉检验。采购惯例以及贸易和监​​管环境的转变，需要定期重新评估以保持其相关性。调查方法的透明化和资料来源的清晰记录有助于对所提出的见解进行深入解读。

总结结论，重点阐述技术创新、医疗保健服务模式的转变以及贸易动态将如何塑造医疗器材製造商和医疗保健系统的战略要务。

中央静脉导管领域正处于曲折点，临床需求、技术创新和外部政策压力正在交汇融合，重塑其应用模式和医疗服务提供者的策略。导管尖端形状、材料和管腔结构的创新，旨在满足更安全、更耐用、更通用的血管通路解决方案的特定临床需求。同时，分散式医疗服务模式和更严格的采购流程，促使人们重新关注医疗总成本和实证差异化。

2025年实施的贸易措施凸显了供应链韧性和区域製造策略的重要性，迫使相关人员在成本优化与不间断的临床供应之间寻求平衡。市场区隔洞察表明，产品选择与特定应用的效能要求和最终用户的实际操作密切相关，能够将设计、证据和支援与临床工作流程相契合的公司将确保更高的市场接受度。总而言之，整合供应链规划、严格临床检验和精准商业化的明智策略行动，对于在这个不断变化的市场环境中获得长期价值至关重要。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将带阀封闭式输液系统应用于肿瘤患者，以最大程度地减少导管相关血流感染疾病
  • 增加抗菌药物浸渍中央静脉导管的使用，以预防加护病房中多重抗药性病原体的滋生
  • 病患活动能力和舒适度的提高推动了周边置入中央静脉导管在家庭输液治疗中的应用日益广泛。
  • 开发用于即时中心静脉压监测和早期併发症检测的压力感测晶片技术
  • 为了提高置入精度并减少机械併发症，对超音波引导置入通讯协定的需求正在激增。
  • 增加可生物降解聚合物涂层导管的投资，以预防血栓症并降低长期併发症率。
  • 具备远端医疗功能和远端监测能力的中心静脉通路装置的出现，为慢性病管理带来了新的机会
  • 推动相关法规，要求使用标准化的封闭式输液装置，以确保危险药物给药过程中的安全性。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型分類的中央静脉导管市场

  • 凹陷端口
  • 非隧道式导管
  • 周边置入中央静脉导管
    • 开放式
    • 阀门晶片
  • 隧道式导管
    • 布罗维亚克
    • 格罗雄
    • 希克曼

第九章 依应用分類的中央静脉导管市场

  • 血液透析机
  • 静脉注射疗法
  • 监测
  • 肠外营养

第十章 依最终使用者分類的中央静脉导管市场

  • 门诊手术中心
  • 透析中心
  • 居家照护
  • 医院
  • 专科诊所

第十一章 依管腔数量分類的中央静脉导管市场

  • 2流明
  • 4流明
  • 1流明
  • 3流明

第十二章中央静脉导管市场（依材质）

  • 聚氨酯
  • 硅酮

第十三章 依尖端形状分類的中央静脉导管市场

  • 非动力注射型
  • 可注入式电源

第十四章 各地区中央静脉导管市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章中央静脉导管市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国中央静脉导管市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Becton, Dickinson and Company
    • Teleflex Incorporated
    • Smiths Group plc
    • B. Braun Melsungen AG
    • Cardinal Health, Inc.
    • ICU Medical, Inc.
    • Medtronic plc
    • Getinge AB
    • AngioDynamics, Inc.
    • Merit Medical Systems, Inc.
Product Code: MRR-02026C4C9BC4

The Central Venous Catheters Market is projected to grow by USD 5.49 billion at a CAGR of 10.00% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.56 billion
Estimated Year [2025] USD 2.81 billion
Forecast Year [2032] USD 5.49 billion
CAGR (%) 10.00%

An authoritative overview of central venous catheter relevance in modern care pathways highlighting clinical, regulatory, and supply chain interdependencies

Central venous catheters remain a foundational element of contemporary acute and chronic clinical care, bridging critical therapeutic, diagnostic, and long-term vascular access needs across diverse patient populations. Their use encompasses hemodialysis, prolonged infusion therapy, central venous pressure monitoring, and parenteral nutrition, creating touchpoints across hospitals, dialysis centers, ambulatory surgical environments, home care settings, and specialty clinics. As clinical expectations evolve, devices themselves are adapting to deliver improved safety, durability, and procedural efficiency while aligning with care delivery models that emphasize outpatient management and reduced hospital length of stay.

Technological refinements in materials, tip configurations, and lumen design are reshaping clinician preferences and procedural workflows. Simultaneously, regulatory scrutiny on device safety and infection prevention continues to influence labeling, claims, and post-market surveillance priorities. Supply chain complexity and procurement policies further affect device selection and availability, making operational readiness and supplier relationships key determinants of clinical continuity. This introduction sets the stage for a deeper examination of the forces redefining central venous catheter strategy across clinical, commercial, and policy domains.

How material innovation, decentralized care delivery, and regulatory scrutiny are collectively redefining device design, procurement, and clinical adoption

The landscape for central venous catheters has undergone rapid and multifaceted transformation driven by innovation, shifting care settings, and changing payer and regulatory expectations. Advances in device design now integrate features such as valve-tip technologies, power-injectable compatibility, antimicrobial coatings, and refined lumen geometries, each responding to tangible clinical needs for reduced infection risk, improved imaging compatibility, and enhanced flow characteristics. These engineering changes have been accompanied by improved materials science where polyurethane and silicone are selected based on trade-offs between flexibility, thrombogenicity, and long-term durability.

Concurrently, care delivery has migrated toward decentralized environments. The expansion of ambulatory surgical centers and robust home care programs has increased demand for devices optimized for outpatient insertion, simplified maintenance, and extended dwell time with minimal complication rates. Value-based procurement models and heightened focus on infection prevention have sharpened attention on total cost of care and clinician training as drivers of device adoption. On the regulatory front, authorities are emphasizing evidence of real-world safety and comparative performance, prompting manufacturers to invest in clinical studies and registries. Lastly, manufacturing and supply chain innovations, including additive manufacturing and supplier consolidation, are altering how devices are produced and distributed, creating both opportunities for localized responsiveness and risks of single-source dependency.

Understanding the strategic and operational consequences of 2025 trade measures on procurement, supply resilience, and manufacturer investment choices

Recent tariff measures implemented in 2025 have altered the cost calculus and operational strategies for stakeholders involved in the central venous catheter ecosystem. Import duties on specific raw materials and finished components have increased procurement costs for manufacturers and distributors that rely on global supply networks. As a result, organizations are reassessing supplier portfolios, negotiating longer-term contracts to stabilize input costs, and evaluating nearshoring or regional sourcing to reduce exposure to tariff volatility and logistical delays.

These trade policy shifts have also had downstream implications for hospital procurement and tender processes. Health systems and group purchasing organizations are revisiting total cost analyses that extend beyond unit pricing to include customs, compliance overhead, and inventory carrying costs. For smaller manufacturers and niche suppliers, the tariff environment compounds margin pressure and can constrain investment in product development and clinical studies. In contrast, larger firms with diversified manufacturing footprints may capitalize on scale to absorb short-term cost shocks while strategically relocating production to tariff-favorable jurisdictions.

Operationally, tariffs have accelerated conversations around inventory buffering, dual-sourcing strategies, and supplier qualification processes. Clinicians may experience transient device substitutions as procurement teams balance availability and cost considerations, underscoring the need for comprehensive clinical evaluation when alternate products are introduced. In sum, tariff-driven dynamics are reshaping commercial strategies, supply chain resilience planning, and innovation investment decisions across the central venous catheter landscape.

Segment-level analysis revealing how product types, clinical applications, end-user profiles, lumen architectures, materials, and tip configurations intersect to drive device selection

A granular understanding of product type segmentation is essential for aligning clinical need with device selection. Implantable ports, non-tunneled catheters, peripherally inserted central catheters with their open-ended and valve-tip variants, and tunneled catheters such as Broviac, Groshong, and Hickman models each address distinct clinical scenarios and duration-of-use expectations. These device classes differ in insertion technique, dwell time, infection risk profile, and maintenance requirements, leading clinicians to favor particular types based on patient comorbidity, expected therapy length, and procedural logistics.

Application-based segmentation underscores where demand for specific features is concentrated. Hemodialysis access demands durable lumens and robust flow characteristics, infusion therapy places a premium on dwell reliability and infection prevention, monitoring requires consistent tip positioning and imaging compatibility, and parenteral nutrition prioritizes long-term patency and biocompatible materials. End-user segmentation shapes distribution and training priorities, as ambulatory surgical centers and specialty clinics emphasize fast turnover and streamlined workflows, dialysis centers focus on high-throughput, home care emphasizes device ease-of-maintenance and caregiver training, and hospitals manage the broadest clinical mix with stringent infection control protocols.

Lumen configuration drives clinical versatility, with single, double, triple, and quadruple lumen devices serving different therapeutic combinations and simultaneous delivery needs. Material choice between polyurethane and silicone reflects a balance between flexibility, thrombogenic potential, and long-term resilience. Tip configuration, distinguished by non power injectable versus power injectable designs, affects compatibility with imaging protocols and interventional workflows. Coordinated product development that aligns these segmentation dimensions with clinician training, supply chain readiness, and reimbursement realities will determine which device classes gain traction in specific care pathways.

Regional dynamics shaping device innovation, regulatory strategy, and supply chain approaches across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics materially influence device design priorities, regulatory pathways, and procurement strategies. In the Americas, a dense network of advanced hospitals and dialysis centers supports rapid adoption of feature-rich devices, while payer structures and group purchasing behaviors shape pricing negotiations and supplier relationships. The Americas also host significant manufacturing capacity, enabling opportunities for localized production to mitigate cross-border trade pressures, which is particularly relevant under shifting tariff regimes.

Europe, the Middle East & Africa present a heterogeneous landscape where regulatory complexity and varied healthcare funding models lead to differentiated adoption patterns. Western European markets often emphasize robust clinical evidence and post-market surveillance, while parts of the Middle East and Africa prioritize supply reliability and cost-effectiveness. Regional distribution networks and partnerships with local providers become critical to reach fragmented markets and to accommodate diverse clinical practices and infrastructure levels.

Asia-Pacific is characterized by dynamic industrial expansion, growing domestic manufacturing capabilities, and rising demand tied to expanding healthcare access. Diverse regulatory frameworks across countries necessitate tailored market entry strategies and often reward manufacturers that can localize production and clinical support. Across all regions, cross-border logistics, customs policy, and trade measures interplay with regional procurement norms, underscoring the importance of region-specific supply chain strategies and clinician engagement programs when introducing new central venous catheter technologies.

How competitive strategies anchored in innovation, clinical evidence, and supply chain optimisation are redefining company positioning and growth pathways

Competitive dynamics within the central venous catheter space are defined by a mix of innovation-driven product firms, specialized manufacturers, and broad-based medical device companies. Market participants are competing along multiple axes including materials science, tip and lumen configuration, infection-mitigation features, and procedural ergonomics. Strategic behavior often centers on deepening clinician relationships through training programs, evidence generation via clinical studies and registries, and expanding distribution through partnerships with regional distributors and integrated supply channel partners.

Innovation investment is increasingly focused on differentiated value propositions such as power-injectable tip configurations, valve technologies that reduce thrombotic risk, and surface treatments intended to lower infection rates. At the same time, commercial strategies emphasize portfolio breadth to address diverse end-user needs from outpatient infusion to dialysis access. Companies are also optimizing manufacturing footprints and considering vertical integration to control quality and responsiveness, particularly where supply chain resilience can be a competitive advantage. Mergers, acquisitions, and licensing arrangements continue to be tools for accelerating access to new technologies and expanding geographic reach, while regulatory compliance and post-market monitoring remain central to sustaining long-term commercial performance.

Strategic priorities for manufacturers and health systems to fortify supply resilience, amplify clinical value, and accelerate adoption across diverse care settings

Industry leaders should prioritize a multi-pronged approach that balances near-term operational resilience with longer-term innovation and clinical value creation. Strengthening supplier diversification and establishing regional manufacturing options can reduce exposure to trade disruptions while improving lead times for high-priority hospital systems. Complementary to supply chain initiatives, investing in clinical evidence generation that demonstrates reductions in infection rates, improved patency, or procedural efficiencies will enhance value-based conversations with payers and procurement committees.

Manufacturers and distributors should also tailor products and support models to the distinct needs of ambulatory surgical centers, dialysis facilities, home care providers, hospitals, and specialty clinics, recognizing that device requirements and training needs differ markedly across these settings. Embracing digital enablement for clinician education, inventory management, and post-market surveillance can increase product stickiness and provide performance data that informs iterative design improvements. Finally, pricing strategies must be aligned with demonstrated outcomes and total cost of care arguments to maintain competitiveness in tender-driven procurement environments, while partnerships with clinical champions can accelerate adoption of high-value features such as power-injectable compatibility and antimicrobial surfaces.

A transparent mixed-method approach blending primary clinician and procurement interviews with systematic secondary synthesis to map device, clinical, and regional dynamics

The research underpinning these insights combines primary qualitative engagement with clinicians, procurement leaders, and device manufacturers alongside systematic review of clinical literature, regulatory documents, and publicly available technical specifications. Primary interviews were conducted to capture frontline perspectives on device selection criteria, procedural workflow implications, and procurement constraints. Secondary analysis synthesized device design trends, materials science developments, and regulatory guidance to triangulate and contextualize interview findings.

Segmentation analysis was applied to align product attributes with clinical applications, end-user capabilities, lumen configurations, material properties, and tip functionalities. Regional assessments incorporated trade policy analysis, healthcare infrastructure indicators, and observed distribution patterns. To bolster robustness, findings were cross-validated through multiple stakeholder interviews and comparison against clinical practice guidelines. Limitations include variability in local procurement practices and the evolving nature of trade and regulatory landscapes, which necessitate periodic reassessment to maintain relevance. Transparency in methodology and clear documentation of data sources support informed interpretation of the insights presented.

Concluding synthesis emphasising how innovation, care delivery shifts, and trade dynamics jointly determine strategic imperatives for device makers and health systems

The central venous catheter domain is at an inflection point where clinical demand, technological innovation, and external policy pressures converge to reshape adoption patterns and supplier strategies. Device innovation in tip configuration, materials, and lumen architecture is responding to concrete clinical needs for safer, more durable, and more versatile vascular access solutions. At the same time, decentralized care delivery models and heightened procurement scrutiny are refocusing attention on total cost of care and evidence-based differentiation.

Trade measures enacted in 2025 have amplified the importance of supply chain resiliency and regional manufacturing strategies, compelling stakeholders to balance cost optimization with uninterrupted clinical availability. Segmentation insights reveal that product choices are tightly coupled to application-specific performance requirements and end-user operational realities, suggesting that companies that can align design, evidence, and support with clinical workflows will secure stronger adoption. Overall, informed strategic action that integrates supply chain planning, rigorous clinical validation, and targeted commercialization will be decisive in capturing long-term value in this evolving landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of valve-equipped closed infusion systems to minimize catheter-related bloodstream infections in oncology patients
  • 5.2. Rising utilization of antimicrobial-impregnated central venous catheters to curb multidrug-resistant pathogen proliferation in ICU settings
  • 5.3. Expansion of peripherally inserted central catheter adoption in home infusion therapy driven by improved patient mobility and comfort
  • 5.4. Development of pressure-sensing tip technology for real-time central venous pressure monitoring and early detection of complications
  • 5.5. Surge in demand for ultrasound-guided insertion protocols to enhance placement accuracy and reduce mechanical complications
  • 5.6. Growing investment in biodegradable polymer-coated catheters to prevent thrombosis and reduce long-term complication rates
  • 5.7. Emergence of telemedicine-enabled central venous access devices with remote monitoring features for chronic care management
  • 5.8. Regulatory push for standardized closed system transfer devices to ensure consistent safety in hazardous drug administration

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Central Venous Catheters Market, by Product Type

  • 8.1. Implantable Port
  • 8.2. Non Tunneled Catheter
  • 8.3. Peripherally Inserted Central Catheter
    • 8.3.1. Open Ended
    • 8.3.2. Valve Tip
  • 8.4. Tunneled Catheter
    • 8.4.1. Broviac
    • 8.4.2. Groshong
    • 8.4.3. Hickman

9. Central Venous Catheters Market, by Application

  • 9.1. Hemodialysis
  • 9.2. Infusion Therapy
  • 9.3. Monitoring
  • 9.4. Parenteral Nutrition

10. Central Venous Catheters Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Dialysis Centers
  • 10.3. Home Care
  • 10.4. Hospitals
  • 10.5. Specialty Clinics

11. Central Venous Catheters Market, by Lumen Number

  • 11.1. Double Lumen
  • 11.2. Quadruple Lumen
  • 11.3. Single Lumen
  • 11.4. Triple Lumen

12. Central Venous Catheters Market, by Material

  • 12.1. Polyurethane
  • 12.2. Silicone

13. Central Venous Catheters Market, by Tip Configuration

  • 13.1. Non Power Injectable
  • 13.2. Power Injectable

14. Central Venous Catheters Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Central Venous Catheters Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Central Venous Catheters Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Becton, Dickinson and Company
    • 17.3.2. Teleflex Incorporated
    • 17.3.3. Smiths Group plc
    • 17.3.4. B. Braun Melsungen AG
    • 17.3.5. Cardinal Health, Inc.
    • 17.3.6. ICU Medical, Inc.
    • 17.3.7. Medtronic plc
    • 17.3.8. Getinge AB
    • 17.3.9. AngioDynamics, Inc.
    • 17.3.10. Merit Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. CENTRAL VENOUS CATHETERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. CENTRAL VENOUS CATHETERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CENTRAL VENOUS CATHETERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY IMPLANTABLE PORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY IMPLANTABLE PORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY IMPLANTABLE PORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY IMPLANTABLE PORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY IMPLANTABLE PORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY IMPLANTABLE PORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON TUNNELED CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON TUNNELED CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON TUNNELED CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON TUNNELED CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON TUNNELED CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON TUNNELED CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY OPEN ENDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY OPEN ENDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY OPEN ENDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY OPEN ENDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY OPEN ENDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY OPEN ENDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY VALVE TIP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY VALVE TIP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY VALVE TIP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY VALVE TIP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY VALVE TIP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY VALVE TIP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY BROVIAC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY BROVIAC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY BROVIAC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY BROVIAC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY BROVIAC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY BROVIAC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY GROSHONG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY GROSHONG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY GROSHONG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY GROSHONG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY GROSHONG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY GROSHONG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HICKMAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HICKMAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HICKMAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HICKMAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HICKMAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HICKMAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY INFUSION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY INFUSION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY INFUSION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY INFUSION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY INFUSION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY INFUSION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY QUADRUPLE LUMEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY QUADRUPLE LUMEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY QUADRUPLE LUMEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY QUADRUPLE LUMEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY QUADRUPLE LUMEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY QUADRUPLE LUMEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POLYURETHANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POLYURETHANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SILICONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SILICONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SILICONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SILICONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON POWER INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON POWER INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON POWER INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON POWER INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON POWER INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON POWER INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POWER INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POWER INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POWER INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POWER INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POWER INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POWER INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 304. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC CENTRAL VENOUS CATHETERS MARKET SIZE,